2019 triangle global health awards
2019 Triangle Global Health
The Triangle Global Health Consortium is pleased to announce our 2019 Triangle Global Health Award Winners. Each year the Triangle Global Health Awards recognize the passion and expertise our local leaders bring to improving the lives of people around the world.
We were extremely impressed with this year's diverse pool of award nominees. Thank you to all who made nominations and congratulations to our 2019 award winners!
global health champion
Pape Gaye, MBA
Pape Gaye, MBA has been selected by the Triangle Global Health Consortium as our 2019 Triangle Global Health Champion in recognition of his life-long commitment to advancing global health.
Pape Gaye is a native of Senegal and a lifelong advocate for health workers, strong health systems, and access to health care for all. Under his leadership as president and CEO of IntraHealth International, the organization has made human resources for health a crucial part of the worldwide conversation on global health. Gaye draws on three decades of leadership in international health and development as he oversees work in over 40 countries to strengthen their health workforces and health systems.
During his watch, IntraHealth has led two of the US government’s flagship human resources for health projects (the Capacity Project and CapacityPlus) and established official relations with the World Health Organization (WHO). Gaye has long advocated for a greater focus on the health workforce. In May 2016 at the World Health Assembly, the WHO and member states responded to such advocacy efforts with the first-ever global health workforce strategy, Workforce 2030.
In the United States, Gaye’s testimony on Capitol Hill during a 2014 Ebola-focused congressional hearing brought the role of frontline health workers to the fore. As a panelist during the White House Global Summit in July 2016, he urged the incoming US president to focus on international aid and human resources for health as powerful investments in our shared future.
Partnership, Gaye believes, is essential. He forges strong collaborative relationships with diverse stakeholders—from ministries of health to private-sector partners to local health workers—to meet the enormous health challenges we face in low- and middle-income countries.
Gaye began his career with the US Peace Corps and went on to work with the 1984 Los Angeles Olympic Committee and the US Centers for Disease Control and Prevention. Before his appointment as CEO at IntraHealth, he led the organization’s regional office for West, Central, and North Africa.
Gaye holds a master’s degree in business administration from the University of California at Los Angeles. His board and advisory services include the Center for African Family Studies, Duke University’s Global Health Institute, Global Health Council, PAI, the Reproductive Health NGO CEO Working Group, Speak Up Africa, and the Triangle Global Health Consortium.
Upon notification of his selection as the 2019 Global Health Champion, Gaye stated, "I am proud to be part of such a vibrant community that is making a real difference. Our collective effort is leading to improvements in the lives of people around the globe and it is exciting to see our Consortium play such a catalytic role in these achievements."
corporate impact award
The Triangle Global Health Consortium is proud to name Grifols as our 2019 Corporate Impact Award winner.
Grifols is a global healthcare company founded in Barcelona in 1940, committed to improving the health and well-being of people around the world. Its four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services in more than 100 countries.
As pioneers in the field of the plasma science, Grifols is one of the largest plasma companies, with a growing network of donation centers worldwide. It develops this plasma into essential medicines used to treat rare, chronic and, at times, life-threatening conditions. As a recognized leader in transfusion medicine, Grifols also offers a comprehensive portfolio of solutions designed to enhance safety from donation through transfusion. And the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care.
In December 2018, Grifols began purifying plasma from healthy Ebola survivors from Liberia to produce anti-Ebola immunoglobulin, a potential treatment for patients affected by the Ebola virus in Africa, as part of a longer-term Grifols clinical research program. Grifols's work includes a first-of-its-kind modular plasma donation center that was deployed to Monrovia, Liberia. Grifols also constructed a dedicated processing facility at its Clayton manufacturing complex to produce anti-Ebola Immunoglobulin. The project is the result of collaborative efforts among Grifols, several non-profit organizations and Liberian scientists at the National Public Health Institute of Liberia. As part of the non-profit project, more than 40 Grifols employees and Probitas Foundation (a Grifols philanthropic organization) professionals traveled to Liberia for extended periods and volunteered in the plasma-collection process and community efforts.
Grifols, with more than 21,000 employees in 30 countries, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry.
ward cates emerging leader award
Dr. Felicia Browne was selected for the Ward Cates Emerging Leader Award based on her demonstrated leadership, innovation, and spirit of collaboration in global health!
Felicia Browne, ScD, MPH
Felicia serves on UNC’s community advisory board for HIV research, is a mentor for WomenNC’s leadership program for college students interested in eliminating gender inequities, and volunteers for a Durham-based organization dedicated to addressing health disparities.
Felicia received her Doctor of Science in Social Epidemiology from Harvard, her MPH in Health Behavior and Health Education from UNC-Chapel Hill, and her BS in Psychology from Davidson College.
Felicia Browne, ScD, MPH, is a social epidemiologist at RTI International in the Substance Use, Gender and Applied Research Program. She has more than a decade of experience adapting and implementing HIV behavioral interventions locally and globally to empower adolescent girls and young women at risk for HIV. She is a Multiple Principal Investigator of a NIDA-funded R01 study testing an mHealth delivery of an HIV prevention intervention in North Carolina health departments for young African American women. She was an integral part of the mHealth development team—ensuring innovative intervention components were included. She is also the Co-Project Director of a NIDA-funded R01 project in South Africa for female adolescents who are out of school, and a Co-Investigator on two NIH-funded R01 projects in South Africa—including one for women living with HIV.